Screener

Net loss

Name: Ligand Pharmaceuticals Net loss by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Ligand Pharmaceuticals·Business Segments·1 segment·Rolls up to Operating Income

Breakdown

Segment	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26	Q2 '26
Business Segments	-$42.45M	$4.85M	$117.27M	$44.78M	-$13.35M	$48.51M
Total	-$36.22M	$8.44M	$54.93M	$13.84M	$17.37M	$8.59M

Business SegmentsView metric